Biotech
-
1.4KPropanc Biopharma Inc (OTCMKTS:PPCB) Showing Signs Of Bouncing After Imploding
Propanc Biopharma Inc (OTCMKTS:PPCB) has come down tumbling after rallying from the $0.08 level to our initial target of $0.20 and generating...
-
1.0KThus Is Why Sunshine Biopharma, Inc. (OTCMKTS:SBFM) Exploded 242%
A 242% surge might as well have reinvigorated Sunshine Biopharma, Inc. (OTCMKTS:SBFM) prospects and sentiments in the market. After coming under immense...
-
2.6KWhy Generex Biotechnology Corporation (OTCMKTS:GNBT) Is Up 700%
Shares of Generex Biotechnology Corporation (OTCMKTS:GNBT) are flirting with record highs on turning bullish after a blockbuster run. The serving of groundbreaking...
-
1.2KNemus Bioscience Inc (OTCMKTS:NMUS) Turns Bullish On Emerald Health $20 Million Credit Line Boost
Nemus Bioscience Inc (OTCMKTS:NMUS) continues to elicit strong investor interest after reaching an agreement for a $20 million credit facility. With the...
-
1.3KGT Biopharma Inc. (OTCMKTS:GTBP): FDA Clinical Trials Clearance Reinvigorates Long-Term Prospects
A third quarter financial report attesting to a solid foundation for long-term growth might as well be the catalyst, poised to trigger...
-
1.3KNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO) Bulls Regain Control
Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) powered high on equity research firm ValueEngine initiating coverage of the stock with a ‘buy’ rating....
-
920Imagin Medical Inc (CNSX:IME) Trying To Bottom Out
Price action activity points to a possible turnaround in Imagin Medical Inc (CNSX:IME) prospects especially on the formation of a double bottom....
-
1.6K1Reliq Health Technologies Inc (CVE:RHT) A Long-Term Play As Demand For Telemedicine Solutions Soar
Reliq Health Technologies Inc (CVE:RHT) is due for a major bounce back after hitting rock bottom. The stock has already bottomed out...
-
3.4K3Why FSD Pharma Inc (CNSX:HUGE) Is A Buy
There are but only a few companies globally which can brag about having doubled their market capitalization over a two-month period. Even...
-
1.1K1Vodis Pharmaceuticals Inc (CNSX:VP): Weak Underlying Fundamentals Spell Trouble Despite Rally
Trading activity around Vodis Pharmaceuticals Inc. (CNSX:VP) stock has picked up the pace, depicted by high turnover in traded shares. However, a 100%...
